BB Biotech AG (BIONn)

Currency in EUR
34.400
-1.200(-3.37%)
Closed·
BIONn Scorecard
Full Analysis
High shareholder yield
High dividend Yield
Fair Value
Day's Range
34.00036.000
52 wk Range
25.65043.350
Key Statistics
Bid/Ask
34.35 / 34.60
Prev. Close
35.6
Open
36
Day's Range
34-36
52 wk Range
25.65-43.35
Volume
16.37K
Average Volume (3m)
12.7K
1-Year Change
-21.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIONn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

BB Biotech AG Company Profile

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Compare BIONn to Peers and Sector

Metrics to compare
BIONn
Peers
Sector
Relationship
P/E Ratio
−4.2x9.6x9.5x
PEG Ratio
0.01−0.220.03
Price/Book
1.0x0.8x1.0x
Price / LTM Sales
−11.6x6.7x2.8x
Upside (Analyst Target)
80.2%37.0%14.3%
Fair Value Upside
Unlock37.4%2.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -8.00%
Dividend Yield
5.47%
Industry Median 2.07%
Annualised payout
1.88
Paid annually
5-Years Growth
-11.94%
Growth Streak

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
-1.83 / --
Revenue / Forecast
397.00K / --
EPS Revisions
Last 90 days

BIONn Income Statement

People Also Watch

5.080
NEXII
+1.40%
595.00
ASML
-2.95%
86.20
DIAS
+0.58%
216.15
PRTP
-0.16%
235.50
TCFP
-0.13%

FAQ

What Stock Exchange Does BB Biotech Trade On?

BB Biotech is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for BB Biotech?

The stock symbol for BB Biotech is "BIONn."

What Is the BB Biotech Market Cap?

As of today, BB Biotech market cap is 1.96B.

What Is BB Biotech's Earnings Per Share (TTM)?

The BB Biotech EPS (TTM) is -8.00.

When Is the Next BB Biotech Earnings Date?

BB Biotech will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is BIONn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has BB Biotech Stock Split?

BB Biotech has split 2 times.

How Many Employees Does BB Biotech Have?

BB Biotech has 10 employees.

What is the current trading status of BB Biotech (BIONn)?

As of 03 Aug 2025, BB Biotech (BIONn) is trading at a price of 34.40, with a previous close of 35.60. The stock has fluctuated within a day range of 34.00 to 36.00, while its 52-week range spans from 25.65 to 43.35.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.